EVALUATION OF MICROALBUMINURIA IN TYPE 2 DIABETIC AND HYPERTENSIVE PATIENT AND ITS CORRELATION WITH DIABETIC NEPHROPATHY

Authors

  • Abukhattala Emhemed Department of Medical Science, Libyan Academy of Graduate studies-Misurata, Libya
  • Alfagieh Esam Department of Medical Laboratory, Faculty of Medical Technology-Misurata, Libya1
  • Bennasr bayio Faiza Department of Medical Laboratory, Faculty of Medical Technology-Misurata, Libya1
  • Khadoura Siham Department of Medical Laboratory, Faculty of Medical Technology-Misurata, Libya1
  • Belgayed Hawa Department of Medical Laboratory, Faculty of Medical Technology-Misurata, Libya1
  • Abu Shiba Esra Department of Medical Laboratory, Faculty of Medical Technology-Misurata, Libya

Keywords:

Microalbuminuria, Hypertension, Diabetic nephropathy

Abstract

Background: This represents an important topic to study because Microalbuminuria is only one earliest sensitive predictor for poor renal outcomes in Type 2 diabetes mellitus and essential hypertension. Objective: Specifically, we aim to investigate the Microalbuminuria and its association with hypertension, diabetic nephropathy, and other diabetic complications. Methods: Eighty-six patients with type 2 diabetes mellitus (41male and 45 female) were enrolled with twenty-five healthy donors (10 male and 15 female). Microalbumin in a random morning urine sample was used and the patients were categorized as micro-albuminuria group, macro-albuminuria group, and control group. Microalbuminuria, glycosylated hemoglobin, serum urea, and creatinine were measured by (COBASIntegra400plus). Results: This approach allows a more detailed analysis of some aspects of the Microalbuminuria data that it was significantly higher in male and female type 2 Diabetes Mellitus compared with the control group (P ≤ 0.022) (P ≤ 0.005) respectively. The most significant observation of this study is that systolic blood pressure was increased among the Microalbuminuria group in females (P ≤ 0.0012), also in the Macro-albuminuria group in males (P ≤ 0.0001), and female (P ≤ 0.0012) and diastolic Blood pressure in male (P ≤ 0.0076). By carefully examining the data, it is found that HbA1c was increased in Microalbuminuria and macro-albuminuria patients with Type 2 Diabetes Mellitus (P ˂ 0.0001) in male and female compared to the control group. The result of this study showed significant increase in urea in macro-albuminuria group in female (≤ 0.0115) and male (≤ 0.0143), and creatinine in male and female (≤ 0.0001) however urea and creatinine increased in Microalbuminuria group in male-only (≤ 0.009) (≤ 0.0003) respectively. On statistical analyses, a strong correlation was found between Microalbuminuria and poor glycemic control in females (R 0.426) also urea in females (r = 0.470) and creatinine in males (r = 0.370) and female (r = 0.716). Conclusion: We have provided further evidence the severity and progression of Diabetes Miletus play an important role in increasing the possibility of diabetic nephropathy and other diabetic complications, regular measurement of Microalbuminuria should delay or prevent the development of end-stage renal disease.

References

Wild S, RoglicG, Green A, SicreeR, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes care. 2004 May 1;27(5):1047-53.

American Diabetes Association. Standards of medical care in diabetes--2012. Diabetes care. 2012 Jan;35:S11.

Borch-Johnsen K, KreinerS. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J (ClinRes Ed). 1987 Jun 27;294(6588):1651-4.

GuK, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the US population, 1971–1993. Diabetes care. 1998 Jul 1;21(7):1138-45.

Sharma SK, GhimireA, RadhakrishnanJ, ThapaL, Shrestha NR, PaudelN, GurungK, BudathokiA, BaralN, Brodie D. Prevalence of hypertension, obesity, diabetes, and metabolic syndrome in Nepal. International journal of hypertension. 2011 Apr 19;2011.

Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension. 1992 May;19(5):403-18.

AlzaidAA. Microalbuminuria in patients with NIDDM: an overview. Diabetes care. 1996 Jan 1;19(1):79-89.

LutaleJJ, ThordarsonH, Abbas ZG, VetvikK. Microalbuminuria among type 1 and type 2 diabetic patients of African origin in Dar EsSalaam, Tanzania. BMC nephrology. 2007 Dec;8(1):2.

LurbeE, Redon J, KesaniA, PascualJM, TaconsJ, Alvarez V, BatlleD. Increase in nocturnal blood pressure and progression to microalbuminuriain type 1 diabetes. New England Journal of Medicine. 2002 Sep 12;347(11):797-805.

Gatling W, Knight C, MulleeMA, Hill RD. Microalbuminuria in diabetes: a population study of the prevalence and an assessment of three screening tests. Diabetic medicine. 1988 May 6;5(4):343-7.

Varghese A, DeepaR, RemaM, Mohan V. Prevalence of microalbuminuriain type 2 diabetes mellitus at a diabetes centrein southern India. Postgraduate medical journal. 2001 Jun 1;77(908):399-402.

PaskoN, TotiF, StrakoshaA, ThengjilliE, ShehuA, DedejT, YlliA, ThereskaN. Prevalence of microalbuminuriaand risk factor analysis in type 2 diabetes patients in Albania: the need for accurate and early diagnosis of diabetic nephropathy. Hippokratia. 2013 Oct;17(4):337.

Lu B, Wen J, Song XY, Dong XH, Yang YH, Zhang ZY, Zhao NQ, Ye HY, MouB, Chen FL, Liu Y. High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes research and clinical practice. 2007 Feb 1;75(2):184-92.

Charlton MR, Wall WJ, OjoAO, GinèsP, TextorS, ShihabFS, MarottaP, CantarovichM, Eason JD, WiesnerRH, Ramsay MA. Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transplantation. 2009 Nov;15(11):S1-34.

AlFehaidAA. Prevalence of microalbuminuriaand its correlates among diabetic patients attending diabetic clinic at National Guard Hospital in Alhasa. Journal of family & community medicine. 2017 Jan;24(1):1.

Ahmad T, UlhaqI, MawaniM, Islam N. Microalbuminuria in Type-2 Diabetes Mellitus; the tip of iceberg of diabetic complications. Pakistan journal of medical sciences. 2017 May;33(3):519.

PalaniappanL, CarnethonM, FortmannSP. Association between microalbuminuriaand the metabolic syndrome: NHANES III. American journal of hypertension. 2003 Nov 1;16(11):952-8.

AnsarMM, ShahrokhiRadR, LebadyMK. Risk factors of microalbuminuriaand macroalbuminuriain type 2 diabetic patients in north of Iran-Rasht. Nephro-Urology Monthly. 2017 Jan 1;9(1).

FarahatTM, ElsaeedGK, GazareenSS, ElsayedTI. Prevalence of proteinuria among type 2 diabetic patients in Menoufiagovernorate, Egypt. MenoufiaMedical Journal. 2014 Apr 1; 27(2):363.

Downloads

Published

2020-01-30

How to Cite

Abukhattala, E., Alfagieh, E., Bennasr bayio, F., Khadoura, S., Belgayed, H., & Abu Shiba, E. (2020). EVALUATION OF MICROALBUMINURIA IN TYPE 2 DIABETIC AND HYPERTENSIVE PATIENT AND ITS CORRELATION WITH DIABETIC NEPHROPATHY. Journal of Academic Research, 15, 57–68. Retrieved from https://lam-journal.ly/index.php/jar/article/view/241

Issue

Section

العلوم الهندسية والتطبيقية